Administration, Intravesical
"Administration, Intravesical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms.
| Descriptor ID |
D000283
|
| MeSH Number(s) |
E02.319.267.120.505
|
| Concept/Terms |
Administration, Intravesical- Administration, Intravesical
- Intravesical Drug Administration
- Drug Administration, Bladder
- Administration, Intravesical Drug
- Administrations, Intravesical Drug
- Drug Administration, Intravesical
- Drug Administrations, Intravesical
- Intravesical Drug Administrations
- Intravesical Administration
- Administrations, Intravesical
- Intravesical Administrations
- Bladder Drug Administration
- Administration, Bladder Drug
- Administrations, Bladder Drug
- Bladder Drug Administrations
- Drug Administrations, Bladder
Instillation, Bladder- Instillation, Bladder
- Bladder Instillation
- Bladder Instillations
- Instillations, Bladder
- Intravesical Instillation
- Instillation, Intravesical
- Instillations, Intravesical
- Intravesical Instillations
Intravesical Injection- Intravesical Injection
- Injections, Intravesical
- Injection, Intravesical
- Intravesical Injections
|
Below are MeSH descriptors whose meaning is more general than "Administration, Intravesical".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intravesical".
This graph shows the total number of publications written about "Administration, Intravesical" by people in this website by year, and whether "Administration, Intravesical" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Intravesical" by people in Profiles.
-
Contieri R, Grajales V, Tan WS, Martini A, Sood A, Hensley P, Bree K, Lobo N, Nogueras-Gonzalez GM, Guo CC, Navai N, Dinney CP, Kamat AM. Impact of age >70?years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Gu?rin. BJU Int. 2024 01; 133(1):63-70.
-
Corsi NJ, Messing EM, Sood A, Keeley J, Bronkema C, Rakic N, Jamil M, Dalela D, Arora S, Piontkowski AJ, Majdalany SE, Butaney M, Rakic I, Li P, Menon M, Rogers CG, Abdollah F. Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc Analysis. Clin Genitourin Cancer. 2022 12; 20(6):e498-e505.
-
Murakami K, Kamat AM, Dai Y, Pagano I, Chen R, Sun Y, Gupta A, Goodison S, Rosser CJ, Furuya H. Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study. Cancer Biomark. 2022; 33(1):151-157.
-
Date AA, Kates M, Yoshida T, Babu T, Afzal U, Kanvinde P, Baras A, Anders N, He P, Rudek M, Hanes J, Bivalacqua TJ, Ensign LM. Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer. Drug Deliv Transl Res. 2021 10; 11(5):2085-2095.
-
Kates M, Date A, Yoshida T, Afzal U, Kanvinde P, Babu T, Sopko NA, Matsui H, Hahn NM, McConkey DJ, Baras A, Hanes J, Ensign L, Bivalacqua TJ. Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer. Clin Cancer Res. 2017 Nov 01; 23(21):6592-6601.
-
Morales A, Cohen Z. Mycobacterium phlei cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin. Expert Opin Biol Ther. 2016; 16(2):273-83.